Securities code: Jinhe Biotechnology Co.Ltd(002688) securities abbreviation: Jinhe Biotechnology Co.Ltd(002688) Announcement No.: 2022020 Jinhe Biotechnology Co.Ltd(002688)
Announcement on no profit distribution in 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important:
● the profit distribution plan for 2021 is: no cash dividend, no bonus shares, and no conversion of provident fund into share capital.
● the profit distribution plan has been deliberated and approved at the 27th meeting of the 5th board of directors and the 17th meeting of the 5th board of supervisors of the company, and needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
1、 2021 profit distribution plan of the company
Audited by ShineWing Certified Public Accountants (special general partnership), the net profit of the company in 2021 was 2374795658 yuan, the statutory surplus reserve was 237479566 yuan, plus the undistributed profit of 36860251301 yuan at the beginning of the year, deducting the profit of 6352896550 yuan of the previous year distributed this year, the profit available for distribution to shareholders in 2021 was 32644670843 yuan.
According to the company’s operation and the need to repay shareholders, the company’s profit distribution plan for 2021 is as follows: no cash dividend, no bonus shares and no conversion of provident fund into share capital in 2021.
2、 Legality and compliance of profit distribution plan
In order to implement the company’s plan on repurchasing some public shares, and taking into account the needs of the company’s daily production and operation, the company plans not to distribute cash dividends, bonus shares or increase share capital with provident fund in 2021. The undistributed profits of the company are used to ensure the daily production and operation development of the company and supplement the needs of working capital.
3、 Opinions of the board of directors
The 27th meeting of the 5th board of directors of the company deliberated and approved the proposal on the company’s profit distribution plan in 2021, and agreed to submit the plan to the company’s 2021 annual general meeting for deliberation.
4、 Opinions of the board of supervisors
The 17th meeting of the 5th board of supervisors of the company deliberated and approved the proposal on the company’s profit distribution plan in 2021, and agreed to submit the proposal to the general meeting of shareholders of the company for deliberation.
5、 Opinions of independent directors
Based on the company’s plan to implement the company’s plan on repurchasing some public shares, and taking into account the needs of the company’s daily production and operation, the company plans not to distribute cash dividends, bonus shares or increase share capital with provident fund in 2021. The undistributed profits of the company are used to ensure the daily production and operation development of the company and supplement the needs of working capital. 6、 Relevant risk tips
This profit distribution plan needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. Please invest rationally and pay attention to investment risks.
It is hereby announced.
Jinhe Biotechnology Co.Ltd(002688) board of directors
April 20, 2022
